A cross-sectional survey of patients and caregivers receiving Blincyto in routine clinical practice in Europe to evaluate the effectiveness of additional risk minimisation measures

First published 22/02/2017

Last updated 22/02/2024

EU PAS number:

EUPAS17829

Study

Finalised

Documents

Study protocol

Initial protocol

20150228 Protocol Ver 1 0 2016-10-18 redaction_Marked

English (2.84 MB - PDF)View document

Updated protocol

01.02.06 Public Redacted Protocol Ver 1.0 2016-11-06 English

First published: 22/02/2024

English (1.98 MB - PDF)View document

Study results

20150228 Observational Research Study Report Published Report_Redacted

English (153.97 KB - PDF)View document

Study report

Other information

Secondary tabs